Adial Pharmaceuticals, Inc.
NASDAQADIL heads into its May 20 earnings print with a sharp price spike and tightening borrow conditions telling a notably conflicted story about where investors stand. The stock has risen 50% over the past week and 28% on Tuesday alone, closing at $2.06. That move has drawn renewed short interest: shares sold short doubled over the past seven trading days, with SI rising 105%…
ADIL short interest
Full pulse commentary is for ORTEX subscribers. The live data picture for ADIL below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for ADIL are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 20 May 2026
ADIL heads into its May 20 earnings print with a sharp price spike and tightening borrow conditions telling a notably conflicted story about where investors stand. The stock has risen 50% over the past week and 28% on…
Adial Pharmaceuticals heads into its May 13 earnings event with short sellers in full retreat — and a surprise Q1 beat already in the market. The most striking move this week is the collapse in short interest. Shorts…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ADIL — free to start on ORTEX.
Sign up for free →Open ADIL on ORTEX